A procedure has been developed for the detection of mycoplasmacidal antibody in the serum of rats and mice infected with Mycoplasma arthritidis. Antibody activity can apparently be measured only by using resting mycoplasma cells. The In 1953 Edward and Fitzgerald reported that rabbit antisera against mycoplasma species were inhibitory to the growth of the organisms when incorporated into the base agar (14).
In 1953 Edward and Fitzgerald reported that rabbit antisera against mycoplasma species were inhibitory to the growth of the organisms when incorporated into the base agar (14) . Variations on their procedure resulted in a simple test in which paper disks impregnated with specific antisera produced zones of growth inhibition on agar plates previously seeded with the homologous organism (7, 24) . More sensitive techniques were devised in which inhibition was measured by the ability of the antiserum to inhibit a color change produced in broth media as a result of the metabolism of a particular substrate by the mycoplasma. Metabolic inhibition tests have now been developed for glucose (25) , arginine (20) , and urea (21) metabolizing mycoplasma species. Growth inhibition by antiserum has also been measured in broth in which reduction of the numbers of colony-forming units (CFU) is observed (23) . Variations on this procedure have resulted in increased sensitivity of the test system (2) . Antibody tests based upon immune inhibition have been found to be highly species specific (7) and have been widely used as indicators of active or past infection.
Previous studies in our laboratories failed to demonstrate the presence of metabolic-inhibiting (MI) or growth-inhibiting (GI) antibody in the sera of rats injected intravenously (i.v.) with Mycoplasma arthritidis (8) . On the other hand, MI antibody was produced against other mycoplasma species similarly injected into rats. Rats did respond weakly to the injection of a mixture of M. arthritidis and Freund adjuvant (9) . Mice exhibited only a weak MI antibody response to M. arthritidis (12) . Recently, evidence was obtained that rats are capable of producing GI antibodies in response to infection by M. arthritidis (11) . Thus, during attempts to demonstrate the phagocytosis of M. arthritidis by murine peritoneal macrophages, it was unexpectedly observed that rat and mouse convalescent sera inhibited the growth of the organisms in the absence of macrophages and yet the same sera had no effect upon the organisms in the presence of macrophages. The base medium alone, consisting of Eagle minimal essential medium (MEM) with 10% (vol/vol) fetal calf serum (FCS), allowed survival of the organisms but did not promote multiplication. When macrophages were present, multiplication of the mycoplasmas occurred. As a result of these studies we suggested that rat and mouse convalescent sera might contain an antibody which was inhibitory to resting mycoplasmas but which had no effect on growing mycoplasmas. The present study was undertaken to confirm the existence of this antibody, to develop procedures for its detection and characterization, and to determine at which stage of the disease it was present.
MATERIALS AND METHODS Strains used. M. arthritidis strains 158 PIO (8) and 158 P10 P9 (13) were used throughout this study. M. hominis strain 14027 and M. arginini 19388 were obtained from the American Type Culture Collection (Rockville, Md.) Cultures and antisera of' M. felis, M. leonis, M. hyorhinis, M. maculosum, and M. meleagridis were as previously described (8, 12) .
Cultivation of mycoplasmas. The base medium used consisted of PPLO agar or broth (Difco) supplemented to a final concentration of 15Y," (vol/vol) sterile horse serum, 5% (vol/vol) sterile yeast extract, and 1,000 U of penicillin G per ml (6, 19) . Mycoplasma suspensions were prepared and counted as described previously (18 Effect of complement on mycoplasmacidal activity. Sera were collected from rats 5 and 28 days after infection with M. arthritidis. By using the microtiter procedure, the f'ollowing systems were compared for mycoplasmacidal antibodv titers: (i) unheated serum; (ii) serum heated at 56 C for 30 min' (iii) heated serum plus 1:25, 1:50, 1:100, 1:200, or 1:400 final dilutions of guinea pig complement. Controls to test the inhibitory effects of all dilutions of guinea pig complement in the absence of antiserum were also set up.
Effect of the growth phase of mycoplasma on susceptibility to antibody. Since M. arthritidis does not actively multiply in complete MEM, mycoplasma broth supplemented with 10'7( (vol/vol) horse serum was used in these studies in addition to MEM supplemented with calf' serum. Microtiter plates were set up containing samples of mycoplasma broth and 5 x 103 CFU of M. arthritidis per well. The dilution of organisms used was prepared from a frozen culture. Serum dilutions containing complement were prepared in advance. In the first experiment the mycoplasma suspensions were counted just before addition of serum and also after 1 and 3 h of' incubation after the addition of serum. In the second experiment, the wells containing the mycoplasma suspensions were preincubated for 1 h at 37 C before addition of serum. As before, the reaction mixtures were counted for mycoplasma after a further I and 3 h of incubation. In the third experiment, the mycoplasma suspensions were preincubated 3 h before addition of the serum PRODUC1'ION OF MY'COPLASMACIDAL ANTIBODY dilutions. As controls, all experiments were repeated by using normal rat serum.
Absorption of serum. Formalin-killed antigen was prepared from a frozen concentrated suspension ot' M. arthritidis, previously adjusted to contain 4 . 10(" CFU per ml. Formalin was added to give a f'inal concentration of' 0.5%( (vol/vol) and the mixture was incubated overnight at 37 C. The suspension was then washed three times by centrif'ugation and was suspended in complete MEM.
Viable antigen was prepared bv centrit'uging a f'resh culture of' M. arthritidis and adjusting the optical density to that of' the Formalin-killed antigen suspension. Additional dilutions containing 4 x 108 and 4 106 CFU per ml were prepared for both antigen suspensions. Absorption was carried out by mixing 0.5-ml amounts of' 5-day rat serum (diluted 1:5 in MEM) with 0.5-ml amounts of' the three concentrations of either Formalin-killed antigen or viable antigen. The mixtures were incubated for 5 h at 37 C on a shaker. Antigen was removed by centrif'ugation. followed by f'iltration through a 0.1-pm membrane t'ilter.
Kinetics of mycoplasmacidal reaction. The test used was a modification of the procedure described bv Brunner et al. (2) for the determination of neutralization of' M. pneumoniae. Complete MEM at 37' C containing 2 . 10 CFU per ml of M. arthritidis strain 158 PIO P9 and 1' (vol/vol) guinea pig complement was distributed into sterile screw-capped tubes (13 bv 100 mm). Sera taken 5 and 28 days after injection of rats with M. arthritidis were heated at 56 C for 30 min and were added to the reaction tubes. The mixtures were incubated at 37 C and 0.2-ml samples were removed after 5, 15, and 30 min and after 1, 2. 4, 6. and 24 h. The samples were immediately added to 1.8 ml of' ice-cold MEM, thus giving a 1: 10 dilution of the reaction mixture. Further dilutions of' 1:100 and 1:1,000 were made, also in ice-cold MEM. The dilutions were plated to mycoplasma agar and were counted by using the standard procedure.
Fractionation of serum. Rat serum was taken t'rom animals 4, 14, and 32 days after i.v. injection of 2 109 CFU of M. arthritidis strain 158 PIO P9. Mouse serum was collected 5 days after the i.v. injection of' 1.5 x 109 CFU of' M. arthritidis strain 158 PIt) P9. Gamma globulin fractions were prepared by ammonium sulfate precipitation as described by Goldman (17) and redissolved to give a twotold concentration over the original serum. The gamma globulin solutions were fractionated on a Sepharose 4B column, as described previously (12) . Protein peaks were measured spectrophotometrically at 280 nm. Selected fractions were dialyzed overnight against distilled water at 6 C and were concentrated 10-t'old by lvophilization prior to testing for mycoplasmacidal activity. (2) . Thus, several antisera were tested for antibody titers before and after filtration through a 0.45-,m membrane filter. No difference was observed in the titers, indicating that M. arthritidis does not readilv agglutinate or clumps.
In order to determine the most suitable number of organisms, reaction mixtures consisting of 5 x 102 to 5 x 105 CFU per ml were tested against both 5-and 28-day rat serum samples. The 5 x 102 inoculum resulted in a barely adequate number of' countable colonies. Complete inhibition was rarely achieved by using the 5 x 104 and 5 x 105 inocula, thus requiring extra dilutions to be made and requiring all dilutions of' serum to be counted. Thus, the most suitable mycoplasma inoculum was considered to be 5 x 103 CFU per ml of reaction mixture. The survival of' some organisms irrespective of serum concentration suggested that a certain proportion were resistant or more resistant to the action of antibody.
Effect of complement. The results are summarized in Fig. 1 Either 5-day convalescent rat serum or normal rat serum mixed with complement were added to the mycoplasma suspension at zero time and after 1 and 3 h of incubation at 37 C. The reaction mixtures were plated out just before addition of serum and after 1 and 3 h of further incubation at 37 C.
By using complete mycoplasma medium, cidal activity was demonstrable only with 1:10 convalescent rat serum. The greatest inhibiting activity occurred when the serum and complement were added without prior incubation of the organisms (Table 2) . A preincubation period of 1 h resulted in less inhibition of organisms and a 3-h preincubation period resulted in no inhibition when serum and complement were added to the system. The organisms did not multiply during the preincubation periods.
Using the MEM base medium preincubation of the organisms before addition of serum had no effect on the mycoplasmacidal titers of the serum which exceeded 1: 160.
Effect of absorption of antiserum with M. arthritidis antigens. The absorption of rat sera with either 1010 CFU of viable M. arthritidis or an identical concentration of Formalin-killed mycoplasma completely eliminated antibody activity. Absorption with 10s-or 106-CFU quantities of antigen reduced the titers two-to fourfold with no difference being apparent between the effectiveness of viable or Formalinkilled antigen preparations in absorbing ability.
Kinetics of mycoplasmacidal reaction. The results, using 5-day convalescent rat serum and 2 x 105 CFU of M. arthritidis per ml, are summarized in Fig. 3 after 2 h and a small proportion of viable organisms persisted through 24 h.
The rapidity of the reaction was confirmed in another experiment in which 5-day rat serum was tested in a reaction mixture containing 6 x 105 CFU of M. arthritidis per ml. A final antiserum concentration of 1:50 resulted in a 95% kill by 30 min and a 99% kill by 1 h. By using 28-day serum, a 90% kill occurred within 30 min and a 99% kill was observed after 2 h.
Fractionation of sera. The 4-day rat serum exhibited antibody exclusively within the immunoglobulin (Ig)M fraction (Fig. 4) . The identity of these antibodies with IgM was confirmed by using a thvroglobulin marker and also by reacting those fractions exhibiting the highest antibody titers with specific goat anti-rat IgM antiserum in a gel diffusion test. Serum taken at 6 weeks was found to exhibit exclusively IgG activitv in the mvcoplasmacidal antibody test (Fig. 5) . Again, the identity of' this antibody with IgG wvas contirmed by using ggoat anti-rat IgG ant iserum.
The antibody titers of whole 14-day rat sera were low and fractionation of this serum resulted only in the detection of low titers of' IgG mycoplasmacidal antibody.
Mouse serum collected 5 days after infection by M. arthritidis exhibited weak mycoplasmacidal activity only within the IgM protein peak. arthritidis strain 158 PIO P9, M. hominis, and M. arginini. Serum taken at 28 days was used in these experiments since it should be less specific than serum taken earlier in the course of infection. The serum exhibited an antibody titer of' 1:1,280 with M. arthritidis antigen but < 1: 5 with the M. hominis and M. arginini antigens.
Mycoplasmacidal and MI activity of hyperimmune rabbit antiserum against M. arthritidis. Rabbit antiserum against M. arthritidis strain 14152 P13 (18) exhibited high titers of complement-dependent mycoplasmacidal antibody against M. arthritidis ( Table 3) . The low titers observed with unheated serum alone reflect the loss of complement during storage of the serum. The cidal antibody titers were 16-to 32-fold higher than the corresponding MI antibody titers.
Relationship of antibody production to the course of experimental disease. Mycoplasmacidal antibody was detected in rats as early as 2 days after infection and the highest mean antibody titers occurred 7 days after infection (Fig.  6) . A decrease in antibody levels was observed at 10 to 14 days. CF antibody was not detected until 5 days after infection. Mycoplasmas were present in the peripheral circulation at least through 5 days, a time at which mycoplasmacidal antibody levels were high. Furthermore, mycoplasmacidal antibody was present at the onset of' arthritis and, in one animal, occurred before the onset of' arthritis. Comparisons of' the data obtained from individual rats failed to demonstrate a relationship between severity of' arthritis and mycoplasmacidal antibody levels. As observed before (8) There was a decrease in mycoplasmacidal antibody at 8 to 10 days, after which the levels increased. As was observed in rats, mycoplasmacidal antibody was present together with circulating viable mycoplasmas. Rats and mice inf'ected many months previously with M. arthritidis were also tested for antibody. Serum samples, taken from three rats approximately 300 days after inf'ection with 5 Production of mycoplasmacidal antibodies in rodents against other mycoplasma species.
The following experiments were undertaken to determine whether the defective antibody response of rats toward M. arthritidis was specific for the latter organism or whether the response of rats to all mycoplasmas was defective.
Rat sera previously prepared (8) Present evidence suggests that mycoplasmacidal antibody produced in rats against M. arthritidis is effective only against "resting" mycoplasmal cells. Thus, rat and mouse cidal antibody was first detected during experiments designed to demonstrate phagocytic action against M. arthritidis (11). In the absence of macrophages, the mycoplasmas were inhibited by convalescent sera. The addition of macrophages resulted in increased mycoplasmal growth and resistance to the cidal properties of serum.
The present study also suggests that antibody is not active in media which permit growth of the organisms, i.e., complete mycoplasma broth. In addition, when high concentrations of convalescent rat serum are used a decreased cidal effect is observed due to the nutritive properties of the serum which render the mycoplasmas more resistant to killing. These observations explain our previous failure to detect metabolic-inhibiting antibody in rats infected with M. arthritidis (8) (10) . This effect was not due to reticuloendothelial blockade. The presence of antibodyresistant cells might also be explained by agglutination resulting in the protection of some organisms. The latter possibility has been found to explain similar observations obtained during virus-neutralization studies (26) .
Mice are also capable of producing a mycoplasmacidal antibody against M. arthritidis. The antibody has been detected as early as 3 days after injection of the organisms and persists for at least 487 days. Whilst the antibody has not yet been characterized, its requirements for activity appear to be similar to those of rat mycoplasmacidal antibody.
In previous studies the failure of rats to produce MI antibody led us to postulate the existence of a heterogenetic antigen common to parasite and host (4, 8) 
